Fierce Pharma Layoff Tracker 2024
Fierce Pharma Layoff Tracker 2024. If there’s been one theme that tells a story about biotech’s situation in 2023, it’s layoffs. The top line sarepta therapeutics abbott fda approval elizabeth holmes layoffs.
Following significant workforce reductions in 2022 and 2023, this year has already seen 60,000 job cuts across 254 companies, according to. Laying off 21% of staff will help extend kronos’ cash runway into the second half of 2026, the company said.
For 2024, Perrigo Expects Organic Net Sales Growth Of 1% To 3%, While.
Perrigo’s restructuring plan came as the company reported $4.7 billion in sales for its 2023 fiscal year, up 4.6% from 2022.
Lyra Lays Off 87 Workers.
The biotech has made its second round of layoffs in five months, with another fifth of its workforce heading to the exits.
As Always, If You Know Of A Layoff Occurring At A Biotech, Please Reach Out To The Fierce Biotech Editorial Team And Let Us Know.
Images References :
Analyzing The Biotech And Pharma Layoffs In 2024.
Several pharma giants have announced multiple waves of layoffs from 2022 to present, including biogen (8 layoff announcements), pfizer (6 layoffs), novartis (5 layoffs) and bayer, zymergen, bristol myers squibb, johnson & johnson, each with 4 layoffs.
J&Amp;J Closed A New Facility In.
The tech layoff wave is still going strong in 2024.